Identification of the immune subtypes associated with the prognosis and immunotherapy of metastatic melanoma
Our immune-associated model may have clinical implications for the prognosis and treatment guidance in patients with metastatic melanoma.
Authors
- Huan‐Zhong Su (ORCID: https://orcid.org/0000-0002-1064-3929)
- Longcheng Hong (ORCID: https://orcid.org/0000-0003-2268-8304)
- Xiaodong Zhang (ORCID: https://orcid.org/0000-0002-1360-2217)
- Feng Zhang
- Yuhui Wu (ORCID: https://orcid.org/0009-0007-9492-7649)
- Chang Shu (ORCID: https://orcid.org/0000-0003-4400-4399)
Institutions
- Chinese Academy of Sciences (CN)
- First Affiliated Hospital of Xiamen University (CN)
- Microbiology Institute of Shaanxi (CN)
- Institute of Microbiology (CN)
Publication Details
- Journal
- Translational Cancer Research
- Published
- 2025-10-01
- DOI
- https://doi.org/10.21037/tcr-2024-2301
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00